Future directions to overcome these challenges include biomarker-driven clinical trials that enrich enrollment with patients exhibiting high mtDAMPs or immune dysfunction, such as testing NLRP3 inhibitors in cardiac surgery patients with elevated preoperative neutrophilplatelet aggregates or high mtDNA levels after CPB, thereby increasing the power to detect benefits in those most likely to respond
While rare, allergic reactions to supplement ingredients can be severe and require prompt treatment
As women, especially those aged 40 and above, experience a decline in natural growth hormone levels, their metabolism tends to slow down, leading to increased fat storage
Earlier Phase 2 Data and Wider Programme The new TRIUMPH-1 results build on earlier Phase 2 data published in The New England Journal of Medicine , which showed an average weight loss of around 24.2% at 48 weeks in adults with obesity
This creates a comprehensive approach to support your long-term health.* All trademarks are the property of their respective owners